NCT01972061

Brief Summary

The purpose of this study is to determine if electrical stimulation of the foot is effective in the treatment of overactive bladder conditions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 18, 2013

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 30, 2013

Completed
4 months until next milestone

Study Start

First participant enrolled

March 1, 2014

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 11, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 11, 2018

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

February 26, 2020

Completed
Last Updated

February 26, 2020

Status Verified

February 1, 2020

Enrollment Period

4.8 years

First QC Date

October 18, 2013

Results QC Date

November 26, 2019

Last Update Submit

February 14, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Urinary Incontinence Episodes Per Day

    Participants kept a daily voiding diary during week 1 (baseline), week 2 (foot stimulation), and week 3 (post foot stimulation). The average number per day urinary incontinence episodes was calculated for week 1 and week 2 for each subject.

    Week 1, Week 2, Week 3

Secondary Outcomes (1)

  • Number of Urinary Urgency Episodes Per Day

    Week 1, Week 2, Week 3

Other Outcomes (2)

  • Bladder Volume as Recorded on CMG for Strong Desire to Void

    CMG #1 and CMG#2

  • Number of Urinary Voids Per Day

    Week 1, Week 2, Week 3

Study Arms (4)

CMG group

EXPERIMENTAL

Foot stimulation will be applied during a cystometrogram (CMG).

Device: Foot stimulation

3 hours group

ACTIVE COMPARATOR

Foot stimulation will be applied daily for 3 hours in the evening.

Device: Foot stimulation

1/2 hour group

ACTIVE COMPARATOR

Foot stimulation will be applied daily for 1/2 hour in the evening.

Device: Foot stimulation

3 hour hand group

ACTIVE COMPARATOR

Hand stimulation will be applied daily for 3 hours in the evening.

Device: Foot stimulation

Interventions

Foot stimulation electrically activates the somatic afferent nerves in the foot using FDA-approved, commercially available transcutaneous electrical nerve stimulator (TENS) and skin surface electrodes attached to the foot.

1/2 hour group3 hour hand group3 hours groupCMG group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • year old men and women and older
  • Currently having overactive bladder (OAB) symptoms, i.e. urgency, frequency, or incontinence
  • No evidence of neurological disorder or urinary tract infection, i.e. clinically diagnosed as idiopathic OAB

You may not qualify if:

  • Pregnant women in their late pregnancy phase will be excluded because the increasing size of the baby/uterus may cause overactive bladder.
  • Patients with implanted electrical stimulators such as pacemaker will be excluded for potential interference with the TENS stimulator.
  • Patients who are allergic to Cipro or Bactrim will be excluded from the CMG study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

MeSH Terms

Conditions

Urinary Bladder, Overactive

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Limitations and Caveats

The 3 hour hand group was not started or completed due to lack of funding.

Results Point of Contact

Title
Dr. Christopher Chermansky
Organization
University of Pittsburgh

Study Officials

  • Christopher Chermansky, MD

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR
  • Dawn McBride, RN

    University of Pittsburgh

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Assistant Professor of Urology

Study Record Dates

First Submitted

October 18, 2013

First Posted

October 30, 2013

Study Start

March 1, 2014

Primary Completion

December 11, 2018

Study Completion

December 11, 2018

Last Updated

February 26, 2020

Results First Posted

February 26, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations